Highline Wealth Partners’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $397K | Buy |
3,581
+19
| +0.5% | +$2.11K | 0.12% | 76 |
|
|
2025
Q1 | $399K | Buy |
3,562
+21
| +0.6% | +$2.35K | 0.13% | 75 |
|
|
2024
Q4 | $327K | Buy |
3,541
+73
| +2% | +$6.74K | 0.11% | 82 |
|
|
2024
Q3 | $291K | Buy |
3,468
+11
| +0.3% | +$922 | 0.1% | 88 |
|
|
2024
Q2 | $237K | Buy |
3,457
+7
| +0.2% | +$480 | 0.09% | 93 |
|
|
2024
Q1 | $253K | Hold |
3,450
| – | – | 0.1% | 90 |
|
|
2023
Q4 | $279K | Hold |
3,450
| – | – | 0.14% | 88 |
|
|
2023
Q3 | $259K | Buy |
3,450
+100
| +3% | +$7.49K | 0.16% | 80 |
|
|
2023
Q2 | $258K | Hold |
3,350
| – | – | 0.16% | 81 |
|
|
2023
Q1 | $278K | Hold |
3,350
| – | – | 0.19% | 80 |
|
|
2022
Q4 | $288K | Hold |
3,350
| – | – | 0.21% | 83 |
|
|
2022
Q3 | $207K | Buy |
+3,350
| New | +$207K | 0.17% | 79 |
|